Table 3. Characteristics of Adult Deceased-Donor Kidney Transplant Patients With Primary Focal Segmental Glomerulosclerosis Receiving Prophylactic Plasmapheresis Who Responded or Did Not Respond to Treatment For Posttransplant Recurrence